Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by I von Muehlenen
THU0174 Drug Retention of Tofacitinib Versus Biologic Antirheumatic Agents in Rheumatoid Arthritis: Observational Data From the Swiss SCQM Registry
Related publications
SAT0200 Biologic Therapy Retention in Rheumatoid Arthritis (RA) Patients (PTS) According to the Moscow Arthritis Registry (MAR)
AB0432 Biologic Dmards Treatment Retention in Patients With Rheumatoid Arthritis According to the Moscow Arthritis Registry (MERA)
Safety of Abatacept Compared With Other Biologic and Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Data From an Observational Study
Arthritis Research & Therapy
Biologic Monotherapy in the Biologic Naïve Patient With Rheumatoid Arthritis (RA): Results From an Observational Study
Rheumatology International
Rheumatology
Allergy
Immunology
FRI0754-HPR Impact of Corticosteroid Utilization on Biologic Disease-Modifying Antirheumatic Drug Initiation Among Patients With Rheumatoid Arthritis
Step-Up Combination Versus Switching of Non-Biological Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results From a Retrospective Observational Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Persistence With Biologic Agents for the Treatment of Rheumatoid Arthritis in Japan
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Use of Biologic Agents in the Treatment of Rheumatoid Arthritis: An Analysis of the Quebec Provincial Drug Reimbursement Program Database
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry
Arthritis Care and Research
Rheumatology
